CompletedNot Applicable

Role of Platelet Rich Plasma in Enhancing Graft Take in Chronic Venous Ulcers

20 participantsStarted 2016-02-01

Plain-language summary

Chronic venous ulcers are considered a problem with a big morbidity impact on both the health facilities and patients, skin-grafting have shown not so perfect outcomes with such ulcers. In this study, the investigators compare combining autologous platelet rich plasma treatments with partial skin grafting in chronic ulcers, the results were compared to using only partial skin grafting, and among various types of chronic resistant ulcers.

Who can participate

Age range12 Years

SexMALE

See this in plain English?

AI-rewrites the medical criteria so a patient or caregiver can understand them. Always confirm with the trial site.

Inclusion criteria: * Patients with chronic ulcers for at least 6 months. * Age ≧ 12 years. Exclusion criteria: * Patients younger than 12 years of age. * Patients with diabetes or other diseases affecting tissue healing. * Patients with current ongoing pathologies in arterial or venous systems. * Patients with malignant ulcers. * Patients on corticosteroids or other drugs affecting tissue healing. * Patients with unrealistic expectations.

What they're measuring

Graft take

Timeframe: month

Trial details

NCT IDNCT03526913

SponsorNoha Mohsen Omar

Sponsor typeOTHER

Study typeINTERVENTIONAL

Primary completion2017-09-01

View on ClinicalTrials.gov More Chronic Venous Hypertension With Ulcer and Inflammation trials